Prolactin-suppressive effects of two aminotetralin analogs of dopamine: their use in the characterization of the pituitary dopamine receptor.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002478:Cells, Cultured; D006220:Haloperidol / Q000494:pharmacology; D008297:Male; D009284:Naphthols / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D010903:Pituitary Gland, Anterior / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D011954:Receptors, Dopamine / Q000502:physiology*; D013329:Structure-Activity Relationship; D013764:Tetrahydronaphthalenes / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology
D009284:Naphthols; D011954:Receptors, Dopamine; D013764:Tetrahydronaphthalenes; D003994:Bucladesine; D011388:Prolactin; D011433:Propranolol; D013806:Theophylline; D006220:Haloperidol; D015056:1-Methyl-3-isobutylxanthine; D010646:Phentolamine